Mar 27, 2025 / 08:30PM GMT
Operator
Greetings and welcome to the Immune BIO's 2024 4th quarter and full year earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and a transcript will follow within 24 hours of this conference call.
At this time, it is now my pleasure to introduce Mr. David Moss, CFO of Immune Bio. David.
David Moss - INmune Bio Inc - Chief Financial Officer
Thank you, Margo and good afternoon everyone. We thank you for joining us for the call for Imu BIO's 2024 4th quarter and full year financial results. With me on the call today is Dr. RJ Tesse, CEO and co-founder of IU Bio, who will provide an update on our clinical programs. Also on the call is Dr. CJ Barnum and Dr. Mark Liddell, who will be available for Q&A.
Before we begin, I remind everyone that except for statements of historical facts, the statements made by management and responses to questions on this conference call are forward-looking statements under the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995. These statements involve
Q4 2024 INmune Bio Inc Earnings Call Transcript
Mar 28, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers